More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
International Media Features HempMeds® Mexico Headquarters Opening

International Media Features HempMeds® Mexico Headquarters Opening

by adminAdrianRamirez | Jul 6, 2017 | Company News, HempMeds Mexico, Media Coverage

[vc_row][vc_column][vc_column_text] The ribbon cutting ceremony for the new HempMeds® Mexico home office in Monterrey last week received coverage in over 140 news outlets, both locally and internationally. HempMeds® Mexico officially put down roots in the country with...
Kannalife Sciences Participates in 27th Annual International Cannabinoid Research Society (ICRS) Symposium

Kannalife Sciences Participates in 27th Annual International Cannabinoid Research Society (ICRS) Symposium

by adminAdrianRamirez | Jul 6, 2017 | Kannalife Sciences, Press Releases

Company Presents Science Behind Mechanism of Action of CBD and its Own Patented CBD-derived Molecule KLS-13019 NEW YORK, July 5, 2017 — Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, announced today that it...
Forbes, Bloomberg, Global Press Cover Medical Marijuana, Inc. Subsidiary HempMeds® Mexico First Office Opening in Monterrey, Mexico

Forbes, Bloomberg, Global Press Cover Medical Marijuana, Inc. Subsidiary HempMeds® Mexico First Office Opening in Monterrey, Mexico

by adminAdrianRamirez | Jul 6, 2017 | HempMeds Mexico, Press Releases

Coverage Also Highlights Company’s Appointment of Renowned Medical Cannabis Advocate and Por Grace Foundation Founder Raul Elizalde as President SAN DIEGO, July 6, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company...
Medical Marijuana, Inc. Subsidiary Dixie Botanicals™ Appoints New Director of Sales and Marketing Brent Albin

Medical Marijuana, Inc. Subsidiary Dixie Botanicals™ Appoints New Director of Sales and Marketing Brent Albin

by adminAdrianRamirez | Jul 5, 2017 | Dixie Botanicals, Press Releases

SAN DIEGO, July 3, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Dixie Botanicals™, one of the most recognizable cannabis brands in the world, has appointed Brent Albin as Director of Sales and Marketing. Medical Marijuana, Inc....
Medical Marijuana, Inc. Subsidiary Kannaway® Appoints New Vice President of Operations Jim Gibson

Medical Marijuana, Inc. Subsidiary Kannaway® Appoints New Vice President of Operations Jim Gibson

by adminAdrianRamirez | Jun 29, 2017 | Kannaway, Press Releases

SAN DIEGO, June 29, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has appointed Jim Gibson as Vice President of Operations. Gibson...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.